Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.88 USD | +1.32% | -3.84% | +23.33% |
Financials (USD)
Sales 2024 * | 19.11M | Sales 2025 * | 97.66M | Capitalization | 3.27B |
---|---|---|---|---|---|
Net income 2024 * | -165M | Net income 2025 * | -126M | EV / Sales 2024 * | 139 x |
Net cash position 2024 * | 620M | Net cash position 2025 * | 516M | EV / Sales 2025 * | 28.2 x |
P/E ratio 2024 * |
-19.8
x | P/E ratio 2025 * |
-25.9
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | +1.32% | ||
1 week | -3.84% | ||
Current month | -1.83% | ||
1 month | -1.55% | ||
3 months | +22.47% | ||
6 months | +65.02% | ||
Current year | +23.33% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
BRD | Director/Board Member | 64 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 43.88 | +1.32% | 729,125 |
24-03-27 | 43.31 | +1.88% | 634,562 |
24-03-26 | 42.51 | +0.47% | 695,749 |
24-03-25 | 42.31 | -1.67% | 670,365 |
24-03-22 | 43.03 | -5.70% | 582,968 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.33% | 3.27B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |